Order Article Reprints

Guillon J, Le Borgne M, Milano V, Guédin-Beaurepaire A, Moreau S, Pinaud N, Ronga L, Savrimoutou S, Albenque-Rubio S, Marchivie M, et al. New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. Pharmaceuticals. 2024; 17(1):30. https://doi.org/10.3390/ph17010030

Guillon, Jean, Marc Le Borgne, Vittoria Milano, Aurore Guédin-Beaurepaire, Stéphane Moreau, Noël Pinaud, Luisa Ronga, Solène Savrimoutou, Sandra Albenque-Rubio, Mathieu Marchivie, and et al. 2024. "New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex" Pharmaceuticals 17, no. 1: 30. https://doi.org/10.3390/ph17010030

Guillon, J., Le Borgne, M., Milano, V., Guédin-Beaurepaire, A., Moreau, S., Pinaud, N., Ronga, L., Savrimoutou, S., Albenque-Rubio, S., Marchivie, M., Kalout, H., Walker, C., Chevallier, L., Buré, C., Largy, E., Gabelica, V., Mergny, J.-L., Baylot, V., Ferrer, J., ... Zupkó, I. (2024). New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. Pharmaceuticals, 17(1), 30. https://doi.org/10.3390/ph17010030